{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:38:39Z","timestamp":1783993119046,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","amjmedsci.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.amjms.2024.02.001","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T16:22:17Z","timestamp":1707322937000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of elexacaftor\/tezacaftor\/ivacaftor on respiratory colonization in an adult cystic fibrosis clinic"],"prefix":"10.1016","volume":"367","author":[{"given":"Michelle M.","family":"Szabo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Foushee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey M.","family":"McPheeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian R.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan M.","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2024.02.001_bib0001","unstructured":"The Clinical and Functional Translation of CFTR (CFTR2). CFTR2 database. Updated April 29, 2022. Accessed January 28, 2023. https:\/\/cftr2.org\/"},{"key":"10.1016\/j.amjms.2024.02.001_bib0002","series-title":"2020 Annual Data Report","year":"2021"},{"key":"10.1016\/j.amjms.2024.02.001_bib0003","unstructured":"Trikafta. Prescribing information. Vertex Pharmaceuticals Incorporated. Accessed February 18, 2022. https:\/\/pi.vrtx.com\/files\/uspi_elexacaftortezacaftor_ivacaftor.pdf"},{"issue":"7","key":"10.1016\/j.amjms.2024.02.001_bib0004","first-page":"e16144","article-title":"A review of Trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy","volume":"13","author":"Zaher","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.amjms.2024.02.001_bib0005","unstructured":"Kalydeco. Prescribing information. Vertex Pharmaceuticals Incorporated. Accessed February 18, 2023. https:\/\/pi.vrtx.com\/files\/uspi_ivacaftor.pdf"},{"issue":"19","key":"10.1016\/j.amjms.2024.02.001_bib0006","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2024.02.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0154-2022","article-title":"Role of inhaled antibiotics in the era of highly effective CFTR modulators","volume":"32","author":"Elborn","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.amjms.2024.02.001_bib0008","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fped.2018.00403","article-title":"Respiratory bacterial culture sampling in expectorating and non-expectorating patients with cystic fibrosis","volume":"6","author":"Eyns","year":"2018","journal-title":"Front Pediatr"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924010590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962924010590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T07:21:29Z","timestamp":1712301689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962924010590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0002962924010590"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2024.02.001","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of elexacaftor\/tezacaftor\/ivacaftor on respiratory colonization in an adult cystic fibrosis clinic","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2024.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}